Filing Details

Accession Number:
0001179110-14-005242
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-14 20:46:15
Reporting Period:
2014-03-14
Filing Date:
2014-03-14
Accepted Time:
2014-03-14 20:46:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1005201 Depomed Inc DEPO Pharmaceutical Preparations (2834) 943229046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529033 M Thadd Vargas C/O Depomed, Inc.
7999 Gateway Boulevard, Suite 300
Newark CA 94560
Senior Vp, Bd No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-14 10,000 $5.08 77,948 No 4 M Direct
Comon Stock Disposition 2014-03-14 63,869 $14.69 14,079 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2014-03-14 10,000 $0.00 10,000 $5.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-12-20 No 4 M Direct
Footnotes
  1. 10,000 stock options were granted on 12/20/2004 and exercisable in 48 equal monthly installments.
  2. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.50 to $14.875. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.